Pasithea Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KTTA and other ETFs, options, and stocks.

About KTTA

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. 

CEO
Tiago Reis Marques
CEOTiago Reis Marques
Employees
4
Employees4
Headquarters
Miami Beach, Florida
HeadquartersMiami Beach, Florida
Founded
2020
Founded2020
Employees
4
Employees4

KTTA Key Statistics

Market cap
5.13M
Market cap5.13M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
97.69K
Average volume97.69K
High today
$0.7151
High today$0.7151
Low today
$0.668
Low today$0.668
Open price
$0.6893
Open price$0.6893
Volume
126.23K
Volume126.23K
52 Week high
$7.50
52 Week high$7.50
52 Week low
$0.668
52 Week low$0.668

People also own

Based on the portfolios of people who own KTTA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.